对TLR4的认识及其与前列腺癌研究进展
被引量:3
摘要
Toll样受体(Toll like receptors,TLRs)是最近发现分布于免疫细胞和大多数恶性肿瘤细胞通过识别配体启动激活免疫应答并参与恶性肿瘤发病机制的一种受体[1]。TLR家族(TLR1-TLR13)中以TLR4的肿瘤表达谱和表达丰度最高,因而TLR4在肿瘤发生发展中的作用备受关注[2]。TLR4与肿瘤的生物学行为密切相关,成为肿瘤免疫领域一个新的研究方向。
出处
《中华全科医学》
2013年第3期461-462,共2页
Chinese Journal of General Practice
参考文献22
-
1Sato Y, Goto Y, Narita N, et al. Cancer cells expressing Toll-like receptom and the tumor microenvironment [ J ]. Cancer microenvironment, 2009,2Suppl1:205-214.
-
2Huang B ,Zhao J,Unkeless JC ,et al. TLR signaling by tumor and immune cells : a double-edged sword [ J ]. Oncogene, 2008,27 ( 2 ) : 218- 224.
-
3Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway [J]. Cytokine,2008,42(2) :145-151.
-
4Tarang S, Kumar S, Batra SK. Mucins and toll-like receptors:kith and kin in infection and cancer[J]. Cancer letters,2012,321 (2) : 110- 119.
-
5嵇武,李宁.Toll样受体与临床疾病关系的研究进展[J].中国误诊学杂志,2007,7(16):3709-3711. 被引量:7
-
6Yang H, Zhou H, Feng P, et al. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion[J]. J Exp Clin Cancer Res,2010,10(29) :92.
-
7Szczepanski M J, Czystowska M, Szajnik M, et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack [ J ]. Cancer Res,2009,69 (7) : 3105-3113.
-
8Zhang J J, Wu HS, Wang L, et al. Expression and significance of TLR4 and HIF-I alpha in pancreatic ductal adenocarcinoma [ J ]. World J Gastroenterol,2010,16 ( 23 ) :2881-2888.
-
9Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells [ J ]. Clin Cancer Res, 2008,14 ( 10 ) : 2909 -2917.
-
10Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-d promotes the development of colitis-associated colorectal tumors [ J ]. Gastroenterology,2007,133 ( 6 ) : 1869 -1881.
二级参考文献12
-
1Gibson FC,Yumoto H,Takahashi Y,et al.Innate immune signaling and porphyromonas gingivalis-accelerated atherosclerosis[J].J dent Res,2006,85(2):106-121.
-
2Cario E,Podolsky DK.Toll-like receptor signaling and its relevance to intestinal inflammation[J].Ann N Y Acad Sci,2006,1072:332-338.
-
3Goepfert AR,Varner M,Ward K,et al.Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy[J].Am J Obstet Gynecol,2005,193 (4):1478-1485.
-
4Lin Y,Zeng Y,Zeng S,et al.Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption[J].Fertil-Steril,2006,85(Suppl 1):1125-1129.
-
5Thornley TB,Brehm MA,Markees TG,et al.TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts[J].J Immunal,2006,176(3):1561-1570.
-
6Obhrai J,Goldstein DR.The roll of toll-like receptors in solid organ transplantation[J].Transplantation,2006,81(4):497-502.
-
7Romagne F.Current and future drugs targeting one class of innate immunity receptors:the Toll-like receptors[J].Drug Discov Today,2007,12(1-2):80-87.
-
8Ishihara S,Rumi MA,Ortega-Cava CF,et al.Therapeutic targeting of toll-like receptors in gastrointestinal inflammation[J].Curr Pharm Des,2006,12(32):4215-4228.
-
9Parker LC,Prince LR,Sabroe I.Translational Mini-Review Series on Toll-like Receptors:Networks regulated by Toll-like receptors mediate innate and adaptive immunity[J].Clin Exp Immunol,2007,147(2):199-207.
-
10Delbridge LM,O'riordan MX.Innate recognition of intracellular bacteria[J].Curr Opin Immunol,2007,19(1):10-16.
共引文献6
-
1张乐逸,张宇飞,嵇武.Toll样受体4的研究进展和临床意义[J].肠外与肠内营养,2009,16(2):123-126. 被引量:8
-
2欧红芹,马向华,沈捷,沈海军.白细胞介素6对人单核/巨噬细胞系细胞表面Toll样受体4表达的影响[J].南京医科大学学报(自然科学版),2010,30(3):319-323. 被引量:4
-
3车金辉,嵇武.Toll样受体激动剂研究进展[J].江苏医药,2012,38(7):834-836. 被引量:4
-
4张溢华,陈礼刚.Toll样受体4与动脉粥样硬化[J].重庆医学,2012,41(12):1223-1225. 被引量:4
-
5林克冰,葛辉,林琪,吴建绍,何丽斌,方琼珊,周宸.斜带石斑鱼TLR5S基因结构及功能分析[J].厦门大学学报(自然科学版),2013,52(1):109-115. 被引量:8
-
6易世杰,赵礼金.TLR4及其作用的研究进展[J].蛇志,2013,25(2):183-187. 被引量:8
同被引文献30
-
1Peter Laszlo Lakatos,Laszlo Lakatos,Ferenc Szalay,Claudia Willheim-Polli,Christoph (O|¨)sterreicher,Zsolt Tulassay,Tamas Molnar,Walter Reinisch,Janos Papp,Gyula Mozsik,Hungarian IBD Study Group,Peter Ferenci.Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations[J].World Journal of Gastroenterology,2005,11(10):1489-1495. 被引量:14
-
2陈刚,秦尚振,马廉亭,雷霆,潘力,薛德麟.成人骨髓间充质干细胞的培养及其向神经元样细胞诱导分化的实验研究[J].中华器官移植杂志,2006,27(2):107-110. 被引量:7
-
3Karthikeyan S,Kanimozhi G,Prasad NR,et al.Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro[J].Toxicology in Vitro,2011,25(7):1366-1375.
-
4Sharma DN,Gandhi AK,Sharma S,et al.Interstitial brachytherapy vs.intensity-modulated radiation therapy for patients with cervical carcinoma not suitable for intracavitary radiation therapy[J].Brachytherapy,2013,12(4):311-316.
-
5Sato Y,Goto Y,Narita N,et al.Cancer Cells Expressing Tolllike Receptors and the Tumor Microenvironment[J].Cancer Microenvironment,2009,2(1):205-214.
-
6González-Reyes S,Marín L,González L,et al.Study of TLR3,TLR4 and TLR9in breast carcinomas and their association with metastasis[J].BMC Cancer,2010,10(1):665.
-
7Li N,Cui X,Ge J,et al.Activin A inhibits activities of lipopolysaccharide-activated macrophages via TLR4,not of TLR2[J].Biochem Biophys Res Commun,2013,435(2):222-228.
-
8Yang H,Zhou H,Feng P,et al.Reduced expression of Tolllike receptor 4inhibits human breast cancer cells proliferation and inflammatory cytokines secretion[J].J Exp Clin Cancer Res,2010,29(1):92.
-
9FrancescoLiotta,RobertaAngeli,LorenzoCosmi,LuciaFilì,CinziaManuelli,FrancescaFrosali,BenedettaMazzinghi,LauraMaggi,AnnalisaPasini,VeronicaLisi,VeronicaSantarlasci,LaraConsoloni,Maria LuciaAngelotti,PaolaRomagnani,PaolaParronchi,MauroKrampera,EnricoMaggi,SergioRomagnani,FrancescoAnnunziato.Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling[J]. STEM CELLS . 2009 (1)
-
10Olga DelaRosa,Eleuterio Lombardo,Andrew Parker.Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential[J].Mediators of Inflammation.2010
引证文献3
-
1程千松,王兴兵,汪健,虞国慧.Toll样受体激动剂对骨髓间充质干细胞成骨及成脂分化的影响[J].安徽医学,2015,36(1):1-4. 被引量:1
-
2吴进盛.TLR4对胃癌细胞放射敏感性的影响探讨[J].成都医学院学报,2014,9(4):421-423.
-
3柳舟,周青山,王璐,董卫国.TLR4Asp299Gly基因多态性与炎症性肠病易感性的Meta分析[J].临床内科杂志,2016,33(8):549-552.
-
1马红,李莉,哈丽哈·赛力克别克,贺继强,伊力亚尔·夏合丁.TLR4和TLR9/NF-κB在食管鳞状细胞癌组织中的表达及其与MMP-9的关系[J].肿瘤防治研究,2012,39(8):1017-1019. 被引量:2
-
2马玉着,章一涓.Toll样受体4和9与宫颈癌的相关研究进展[J].山东医药,2013,53(41):97-99. 被引量:1
-
3徐娟,潘世扬,黄珮珺,娄鉴芳,朱胜江,黄蕾,韩月,史新惠,孙瑞红,王芳.Toll样受体在卵巢癌发生发展中作用机制的初步探讨[J].南京医科大学学报(自然科学版),2013,33(3):308-313. 被引量:4
-
4虞同华,张映,郝汉霞,吴文澜.Toll样受体在甲状腺未分化癌细胞株DRO中的表达[J].江苏医药,2010,36(17):2060-2063.
-
5徐娟,王芳,娄鉴芳,史新惠,黄蕾,张淑平,柯星,孙瑞红,彭启松.TLR1、TLR2和TLR6在卵巢癌患者PBMC细胞亚群中的表达和功能初探[J].南京医科大学学报(自然科学版),2014,34(12):1638-1643. 被引量:1
-
6王丽娟,蔡真.Toll样受体和血液系统恶性肿瘤的研究进展[J].中国肿瘤生物治疗杂志,2009,16(3):301-304. 被引量:6
-
7张彩,冯进波,王郡甫,许晓群,张建,田志刚.膜型分泌型MICA对NK细胞受体NKG2D的相反调节效应及其对NK细胞受体谱的影响[J].中华微生物学和免疫学杂志,2004,24(2):107-111. 被引量:33
-
8徐娟,黄珮珺,潘世扬,史新惠,娄鉴芳,黄蕾,徐婷,孙瑞红,刘园,王芳.卵巢癌患者TLR1、TLR2、TLR6信号通路活化诱导PBMC前炎症细胞因子分泌[J].临床检验杂志,2013,31(8):584-587. 被引量:4
-
9牟崇云,秦凯凯,姜相君.Toll样受体1基因多态性及幽门螺杆菌感染与胃癌的相关性[J].中国医药,2016,11(6):848-852. 被引量:4
-
10杨绿原,黄江菊.固有免疫受体TLR9在鼻咽癌与癌旁组织中的表达[J].免疫学杂志,2015,31(5):375-379. 被引量:2